What's Happening?
Healthcare CFO turnover reached a five-year high of 23% in 2025, according to Russell Reynolds Associates. This increase in turnover is reshaping the healthcare CFO market, as more CFOs are stepping away from full-time executive roles, tightening the talent
market. The report highlights that 75% of external CFO appointments from 2021-2025 had prior CFO experience, indicating a preference for proven leaders. The turnover is attributed to factors such as margin pressure, portfolio optimization, and regulatory complexity. The analysis covered CFO transitions across biopharma, medtech, healthcare services, and healthtech organizations in 13 leading global public indexes from 2021 to 2025.
Why It's Important?
The high turnover rate among healthcare CFOs is significant as it underscores the challenges in maintaining leadership continuity in a sector facing complex financial and regulatory environments. The shortage of experienced CFOs could impact strategic decision-making and value creation, affecting capital allocation and investor relations. Organizations may need to prioritize internal succession planning to ensure leadership stability. The trend also highlights the need for diversity, as women hold less than a quarter of healthcare CFO appointments, indicating a gap in gender representation in leadership roles.
What's Next?
Organizations are advised to treat CFO succession as a strategic priority, anticipating changes earlier and maintaining an active view of succession risk and readiness. This includes developing internal finance talent and ensuring a pathway for women into CFO roles. With a shrinking pool of experienced CFOs, companies may need to broaden their search to adjacent sectors and align expectations with the available talent supply. The focus will likely be on building a CFO-readiness engine to prepare candidates for future leadership roles.
